concept

AMYLOID PET

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID PET: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

33Connections
3Hypotheses
2Analyses
18Outgoing
15Incoming
0Experiments
3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAMYLOID PET
Key Genes/ProteinsAMYLOID, AMYLOID-BETA
Related DiseasesAGING, ALS, ALZHEIMER, ALZHEIMER'S DISEASE, BBB DISRUPTION

Pathway Diagram

graph TD
    AMYLOID_PET[AMYLOID PET]
    AMYLOID_PET -.biomarker for.-> AD_Neuropathologic_Change[AD Neuropathologic Change]
    AMYLOID_PET -.biomarker for.-> Alzheimer_s_Disease[Alzheimer's Disease]
    AMYLOID_PET -->|phosphorylates| TAU[TAU]
    COGNITIVE_DECLINE[COGNITIVE DECLINE] -->|regulates| AMYLOID_PET

Outgoing (18)

TargetRelationTypeStr
AD Neuropathologic Changebiomarker_forprocess0.90
Alzheimer's Diseasebiomarker_fordisease0.88
p-tau217correlates_withbiomarker0.70
TAUphosphorylatesprotein0.65
ALZHEIMERassociated_withdisease0.50

Incoming (15)

SourceRelationTypeStr
CSF p-tau217normalizes_beforebiomarker0.70
COGNITIVE DECLINEregulatesphenotype0.65
36544184return towards pre-randomization levels more quickly thanpaper0.60
VISUAL CORTEXassociated_withbrain_region0.50
GFAPassociated_withgene0.50

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Temporal Decoupling of CSF p-tau217 Normalization from Amylo 0.595 neurodegeneration -
CSF p-tau217 Normalization Occurs Earlier Than Amyloid PET N 0.565 - Can CSF p-tau217 normalization serve as
Multi-Biomarker Composite Index Surpassing Amyloid PET for T 0.559 neurodegeneration Multi-modal Biomarker Panel Design for E

Mentioning Analyses (2)

Scientific analyses that reference this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.585

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.559

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (6)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567] Guerreiro S, Privat AL, Bressac L, Toulo Cells 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567] Guerreiro S, Privat AL, Bressac L, Toulo Cells 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0

Debates (3)

Multi-agent debates referencing this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning AMYLOID PET in their description or question text

No additional research found